This discrepancy is not shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, which have identical or better potencies than copyright as dopamine reuptake inhibitors. These results have evoked a speculation that copyright might also perform like a so-known as "DAT inverse agonist" or "detrimental allosteric modifier https://raymondh970pvn7.oblogation.com/profile